0001209191-15-058117.txt : 20150701
0001209191-15-058117.hdr.sgml : 20150701
20150701172709
ACCESSION NUMBER: 0001209191-15-058117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150701
FILED AS OF DATE: 20150701
DATE AS OF CHANGE: 20150701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 662-2000
MAIL ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gershkowitz Jayne
CENTRAL INDEX KEY: 0001569157
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 15966206
MAIL ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-07-01
0
0001178879
AMICUS THERAPEUTICS INC
FOLD
0001569157
Gershkowitz Jayne
1 CEDAR BROOK DRIVE
CRANBURY
NJ
08512
0
1
0
0
SVP, Chief Patient Advocate
Common stock
2015-07-01
4
M
0
10649
13.9748
A
16342
D
Common stock
2015-07-01
4
S
0
10649
13.9748
D
5693
D
Stock Options (right to buy)
3.53
2015-07-01
4
M
0
4374
0.00
D
2014-01-28
2023-01-28
Common Stock
4374
26252
D
Stock Options (right to buy)
2.52
2015-07-01
4
M
0
3463
0.00
D
2014-06-18
2023-06-18
Common stock
3463
28075
D
Stock Options (right to buy)
2.45
2015-07-01
4
M
0
2812
0.00
D
2015-01-03
2024-01-03
Common stock
2812
39376
D
The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.87 to $14.15. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.87 to $14.15. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Jayne Gershkowitz
2015-07-01